SCHEMBL6000970

SCHEMBL6000970

CC(C)(C[O])N1CCCC1

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.33
CYP2B6 P20813 1/20 0.32
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24663779 0.77 CYP2B6 (0.34) NPC1CYP2B6
SCHEMBL25131531 0.76 CYP2B6 (0.35) NPC1CYP2B6
SCHEMBL178517 0.74 CYP2B6 (0.33) NPC1CYP2B6
SCHEMBL23336586 0.74 CYP2B6 (0.38) NPC1CYP2B6KMT2A
SCHEMBL22871678 0.74 CYP2B6 (0.38) NPC1CYP2B6KMT2A
SCHEMBL11587102 0.72 CYP2B6 (0.37) NPC1CYP2B6KMT2A
SCHEMBL9925976 0.72 CYP2B6 (0.37) NPC1CYP2B6KMT2A
SCHEMBL8508540 0.72 CYP2B6 (0.37) NPC1CYP2B6KMT2A
SCHEMBL3634951 0.72 CYP2D6 (0.33) NPC1CYP2B6
SCHEMBL22485468 0.72 CYP2B6 (0.32) NPC1CYP2B6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678185-A1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-07-12 EP disclosed
WO-2005042542-A1 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-05-12 WO disclosed
EP-0138684-A2 2-(N-pyrrolidino)-3-isobutoxy-N-phenyl-substituted N-benzylpropyl amines, their preparation and their pharmaceutical use RIOM LABORATOIRES- C.E.R.M. "R.L.-CERM" - (S.A.) (FR) 1985-04-24 EP disclosed